Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Geschwind

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Biological Psychiatry|October 24, 2007
Autism: searching for coherenceDaniel Geschwind
Human Molecular Genetics|October 21, 2022
Human Molecular Genetics Review Issue 2022Feixiong Cheng, Daniel Geschwind
Neuron|September 10, 2020
Selective Neuronal Vulnerability in Alzheimer's Disease: A Modern Holy GrailJessica Rexach, Daniel Geschwind
Biological Psychiatry|March 18, 2014
Neurodegenerative dementias: connecting psychiatry and neurology through a shared neurobiologyDaniel Geschwind, Eric J Nestler
International Psychogeriatrics|May 28, 2009
Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementiaDiana Lynn Woods, Brittany Bushnell, Haesook Kim, et al.
Molecular Autism|February 24, 2023
Sex differences in friendships and loneliness in autistic and non-autistic children across developmentNatalie Libster, Azia Knox, Selin Engin, et al.
Molecular Autism|December 24, 2022
Personal victimization experiences of autistic and non-autistic childrenNatalie Libster, Azia Knox, Selin Engin, et al.
British Journal of Pharmacology|May 6, 2011
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cellsAna Juknat, Maciej Pietr, Ewa Kozela, et al.
Experimental Neurology|October 7, 2009
A human neuron injury model for molecular studies of axonal regenerationLina Ziegler, Yael Segal-Ruder, Giovanni Coppola, et al.
Plos One|May 3, 2013
Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsAna Juknat, Maciej Pietr, Ewa Kozela, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Biological Psychiatry|October 24, 2007
Autism: searching for coherenceDaniel Geschwind
Human Molecular Genetics|October 21, 2022
Human Molecular Genetics Review Issue 2022Feixiong Cheng, Daniel Geschwind
Neuron|September 10, 2020
Selective Neuronal Vulnerability in Alzheimer's Disease: A Modern Holy GrailJessica Rexach, Daniel Geschwind
Biological Psychiatry|March 18, 2014
Neurodegenerative dementias: connecting psychiatry and neurology through a shared neurobiologyDaniel Geschwind, Eric J Nestler
International Psychogeriatrics|May 28, 2009
Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementiaDiana Lynn Woods, Brittany Bushnell, Haesook Kim, et al.
Molecular Autism|February 24, 2023
Sex differences in friendships and loneliness in autistic and non-autistic children across developmentNatalie Libster, Azia Knox, Selin Engin, et al.
Molecular Autism|December 24, 2022
Personal victimization experiences of autistic and non-autistic childrenNatalie Libster, Azia Knox, Selin Engin, et al.
British Journal of Pharmacology|May 6, 2011
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cellsAna Juknat, Maciej Pietr, Ewa Kozela, et al.
Experimental Neurology|October 7, 2009
A human neuron injury model for molecular studies of axonal regenerationLina Ziegler, Yael Segal-Ruder, Giovanni Coppola, et al.
Plos One|May 3, 2013
Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsAna Juknat, Maciej Pietr, Ewa Kozela, et al.
Pageof 7